ask="N/A"
ask_size="N/A"
average_daily_volume="204577"
bid="2.76"
bid_size="200"
book_value="0.56"
change="-0.13"
change_from_200_day_moving_average="0.58"
change_from_50_day_moving_average="0.33"
change_from_52_week_high="-0.86"
change_From_52_week_low="0.95"
change_in_percent="-4.16%"
close="3.01"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-0.31"
ebitda="-5.76M"
eps_estimate_current_year="-0.30"
eps_estimate_next_quarter="-0.21"
eps_estimate_next_year="-0.91"
ex_dividend_date="N/A"
float_shares="16233000"
high="3.40"
high_52_weeks="3.87"
last_trade_date="2/2/2017"
last_trade_price="3.01"
last_trade_size="401"
last_trade_time="4:00pm"
low="2.90"
low_52_weeks="2.06"
market_capitalization="56.25M"
moving_average_200_day="2.43"
moving_average_50_day="2.68"
name="Brainstorm Cell Therapeutics In"
notes="N/A"
one_year_target_price="6.00"
open="3.20"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+23.88%"
percent_change_from_50_day_moving_average="+12.33%"
percent_change_from_52_week_high="-22.22%"
percent_change_from_52_week_low="+46.12%"
previous_close="3.14"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="5.58"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="18687000"
short_ratio="1.29"
stock_exchange="NCM"
symbol="BCLI"
volume="564080"
weeks_range_52="2.06 - 3.87"
